Jefferies Financial Group Inc. acquired a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 3,379,813 shares of the company’s stock, valued at approximately $47,960,000.
Other institutional investors have also recently modified their holdings of the company. EverSource Wealth Advisors LLC raised its position in shares of Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares during the last quarter. Bayforest Capital Ltd acquired a new position in shares of Acadia Healthcare during the 4th quarter worth approximately $52,000. Hantz Financial Services Inc. raised its position in shares of Acadia Healthcare by 501.9% during the 3rd quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock worth $54,000 after purchasing an additional 1,822 shares during the last quarter. GAMMA Investing LLC raised its position in shares of Acadia Healthcare by 124.7% during the 4th quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock worth $69,000 after purchasing an additional 2,698 shares during the last quarter. Finally, Covestor Ltd raised its position in shares of Acadia Healthcare by 36.0% during the 3rd quarter. Covestor Ltd now owns 6,004 shares of the company’s stock worth $149,000 after purchasing an additional 1,589 shares during the last quarter.
Acadia Healthcare Stock Up 0.7%
Shares of Acadia Healthcare stock opened at $23.18 on Friday. The company has a fifty day moving average price of $25.21 and a 200 day moving average price of $19.32. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.27. Acadia Healthcare Company, Inc. has a twelve month low of $11.43 and a twelve month high of $30.20. The stock has a market cap of $2.13 billion, a price-to-earnings ratio of -1.89, a price-to-earnings-growth ratio of 7.79 and a beta of 0.73.
Wall Street Analyst Weigh In
Several research analysts recently issued reports on the company. Guggenheim lifted their price objective on Acadia Healthcare from $26.00 to $31.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. Leerink Partners lifted their price objective on Acadia Healthcare from $14.00 to $22.00 and gave the stock a “market perform” rating in a research report on Thursday, February 26th. TD Cowen lifted their target price on shares of Acadia Healthcare from $24.00 to $30.00 and gave the stock a “buy” rating in a research note on Tuesday, April 28th. Raymond James Financial raised shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 target price for the company in a research note on Monday, May 4th. Finally, Cantor Fitzgerald lifted their target price on shares of Acadia Healthcare from $20.00 to $30.00 and gave the stock a “neutral” rating in a research note on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $26.04.
Read Our Latest Stock Report on Acadia Healthcare
About Acadia Healthcare
Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.
Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.
See Also
- Five stocks we like better than Acadia Healthcare
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report).
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
